BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12351596)

  • 1. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
    Iwashyna TJ; Lamont EB
    J Clin Oncol; 2002 Oct; 20(19):3992-8. PubMed ID: 12351596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.
    Sundararajan V; Mitra N; Jacobson JS; Grann VR; Heitjan DF; Neugut AI
    Ann Intern Med; 2002 Mar; 136(5):349-57. PubMed ID: 11874307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study.
    Neugut AI; Fleischauer AT; Sundararajan V; Mitra N; Heitjan DF; Jacobson JS; Grann VR
    J Clin Oncol; 2002 Jun; 20(11):2643-50. PubMed ID: 12039925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
    Schrag D; Rifas-Shiman S; Saltz L; Bach PB; Begg CB
    J Clin Oncol; 2002 Oct; 20(19):3999-4005. PubMed ID: 12351597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of different chemotherapeutic regimens on survival of people aged 66 and older with stage III colon cancer: a "real world" analysis using Surveillance, Epidemiology, and End Results-Medicare data.
    Hsiao FY; Mullins CD; Onukwugha E; Pandya N; Hanna N
    J Am Geriatr Soc; 2011 Sep; 59(9):1717-23. PubMed ID: 21831168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer.
    Hu CY; Chan W; Delclos GP; Du XL
    Am J Clin Oncol; 2012 Jun; 35(3):228-36. PubMed ID: 21383605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009.
    Du XL; Zhang Y; Parikh RC; Lairson DR; Cai Y
    J Am Geriatr Soc; 2015 Aug; 63(8):1570-82. PubMed ID: 26200214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.
    Neugut AI; Matasar M; Wang X; McBride R; Jacobson JS; Tsai WY; Grann VR; Hershman DL
    J Clin Oncol; 2006 May; 24(15):2368-75. PubMed ID: 16618946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study.
    Sundararajan V; Grann VR; Jacobson JS; Ahsan H; Neugut AI
    Cancer J; 2001; 7(3):213-8. PubMed ID: 11419029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
    Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
    Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia.
    Gupta SK; Lamont EB
    J Am Geriatr Soc; 2004 Oct; 52(10):1681-7. PubMed ID: 15450045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer.
    Dietmaier W; Bettstetter M; Wild PJ; Woenckhaus M; Rümmele P; Hartmann A; Dechant S; Blaszyk H; Pauer A; Klinkhammer-Schalke M; Hofstädter F
    Int J Cancer; 2006 May; 118(9):2247-54. PubMed ID: 16331619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
    Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
    J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
    Gross CP; McAvay GJ; Guo Z; Tinetti ME
    Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.